Does insurance cover tirzepatide?
Quick answer
Coverage varies widely. Some commercial plans cover Zepbound for weight loss or Mounjaro for diabetes. Many don't. Medicare does not cover weight loss medications. Compounded tirzepatide through providers like LYV offers a more affordable alternative at $197/month without insurance hurdles.
The current insurance landscape
Brand-name tirzepatide (Mounjaro for diabetes, Zepbound for weight loss) lists at $900-1,100+ per month. Insurance coverage depends on your specific plan, the indication (diabetes vs weight loss), and prior authorization requirements.
For type 2 diabetes (Mounjaro): coverage is better. Most commercial plans cover GLP-1 drugs for diabetes, though prior authorization is common. You may need to show that metformin alone was insufficient.
For weight loss (Zepbound): coverage is inconsistent. Some large employers and commercial plans cover anti-obesity medications. Many exclude them. Step therapy requirements (trying other drugs first) are common.
Medicare and Medicaid
Medicare Part D does not cover drugs prescribed for weight loss. This is a statutory exclusion from 2003 that Congress has not yet overturned, despite bipartisan efforts. Medicare does cover Mounjaro for type 2 diabetes, but not Zepbound for obesity.
Medicaid coverage varies by state. Some state Medicaid programs cover anti-obesity medications, others don't. Check your specific state program. Even in states that cover it, prior authorization requirements can create delays.
How to check your coverage
Call the number on your insurance card and ask specifically: "Does my plan cover Zepbound (tirzepatide) for weight management?" and "Does my plan cover Mounjaro (tirzepatide) for type 2 diabetes?" Get the answer in writing if possible.
Ask about: prior authorization requirements, step therapy requirements (drugs you need to try first), quantity limits, preferred pharmacy requirements, and your copay/coinsurance amount. Some plans cover it but with a $300-500/month copay, which isn't much better than paying cash for compounded versions.
The compounded alternative
Compounded tirzepatide is manufactured by licensed US compounding pharmacies and prescribed by licensed providers. It contains the same active ingredient at the same doses. It's available without insurance at a fraction of brand cost.
LYV offers compounded tirzepatide starting at $197/month. This includes the prescriber consultation, the medication, and shipping. No insurance claims, no prior authorizations, no surprise bills. For many patients, this is simpler and cheaper than navigating insurance coverage for brand-name versions.
Learn more about Tirzepatide
Frequently asked questions
How much does tirzepatide cost without insurance?
Brand Zepbound/Mounjaro lists at $900-1,100/month at retail pharmacies. Manufacturer savings cards can reduce this to $500-550/month for eligible patients. Compounded tirzepatide through LYV starts at $197/month with no insurance needed.
Is compounded tirzepatide the same as Mounjaro?
Compounded tirzepatide contains the same active molecule. It's prepared by licensed 503A or 503B pharmacies under FDA oversight. The difference is the formulation may include different inactive ingredients. The therapeutic effect is the same at equivalent doses.
Will insurance ever cover weight loss drugs?
Legislation (the Treat and Reduce Obesity Act) has been introduced repeatedly in Congress to remove the Medicare exclusion for anti-obesity drugs. Coverage is trending toward expansion as obesity is increasingly recognized as a chronic disease. Some major employers have already added coverage.
Get the right protocol for your goals
Take a 2-minute quiz. Matched to your health profile by a licensed provider.